Chong-kil W. Lee

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

The preventive effect of solubilized sturgeon oil on dextran sulfate sodium-induced ulcerative colitis via inflammation attenuation and intestinal microbiota regulation.

The preventive effect of solubilized sturgeon oil on dextran sulfate sodium-induced ulcerative colitis via inflammation attenuation and intestinal microbiota regulation.

Journal: Food & function

Published: June 09, 2025

Modulation of Immune Responses by Metabolic Reprogramming: The Key Role of Immunometabolism.

Modulation of Immune Responses by Metabolic Reprogramming: The Key Role of Immunometabolism.

Journal: Immune network

Published: February 22, 2025

Exploring the Preventive Potential of Solubilized Sturgeon Oil on Acute Infection with Respiratory Viruses.

Exploring the Preventive Potential of Solubilized Sturgeon Oil on Acute Infection with Respiratory Viruses.

Journal: Marine drugs

Published: December 27, 2024

Hair Growth Promoting Effects of Solubilized Sturgeon Oil and Its Correlation with the Gut Microbiome.

Hair Growth Promoting Effects of Solubilized Sturgeon Oil and Its Correlation with the Gut Microbiome.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 31, 2024

Cytokines and Immune Disorders: Illuminating Cytokines as Hubs Within the Immune Network.

Cytokines and Immune Disorders: Illuminating Cytokines as Hubs Within the Immune Network.

Journal: Immune network

Published: February 14, 2024

COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants.

COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants.

Journal: Immune network

Published: December 21, 2022

Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody.

Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody.

Journal: Immune network

Published: October 05, 2022

A Novel Bacterium, Butyricimonas virosa, Preventing HFD-Induced Diabetes and Metabolic Disorders in Mice via GLP-1 Receptor.

A Novel Bacterium, Butyricimonas virosa, Preventing HFD-Induced Diabetes and Metabolic Disorders in Mice via GLP-1 Receptor.

Journal: Frontiers in microbiology

Published: January 19, 2022

Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes.

Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes.

Journal: Immune network

Published: November 17, 2021

New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axis.

New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axis.

Journal: Clinical and translational medicine

Published: October 04, 2021

MUL1-RING recruits the substrate, p53-TAD as a complex with UBE2D2-UB conjugate.

MUL1-RING recruits the substrate, p53-TAD as a complex with UBE2D2-UB conjugate.

Journal: The FEBS journal

Published: June 20, 2021

Efficacy of Local Minocycline Agents in Treating Peri-Implantitis: An Experimental In Vivo Study in Beagle Dogs.

Efficacy of Local Minocycline Agents in Treating Peri-Implantitis: An Experimental In Vivo Study in Beagle Dogs.

Journal: Pharmaceutics

Published: October 05, 2020

Showing 1-12 of 57

Last Updated: 09/26/2026